About Atomwise
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
|
|
11-50 employees
View all Atomwise employees
|
|
Biotechnology
|
|
717 Market St., Suite 800, San Francisco, California 94103, US
|
|
2012
|
|
Drug Discovery, Artificial Intelligence, Machine Learning, Computer Aided Drug Design
|
Atomwise Alternatives
Frequently Asked Questions about Atomwise
J Suzette Medina is the CEO of Atomwise.
The decision makers in Atomwise are Cameron Ferroni, Diane Krzysik, Ed Kawashiri, etc. Click to Find Atomwise decision makers emails.
You can reach Atomwise by visiting their website's contact page, where you'll find a form to submit your inquiries. Additionally, you can email them directly at [email protected] for more specific questions related to their drug discovery services.
Atomwise does not publicly provide a detailed staff directory. However, you can find information about key team members, including the Board of Directors and Scientific Advisory Board, on their website under the 'About Us' section.
Atomwise primarily supports the pharmaceutical and biotech industries by leveraging AI and machine learning to enhance drug discovery processes. Their technology is designed to accelerate the development of new therapeutics across various therapeutic areas.
Yes, Atomwise welcomes collaboration opportunities. Interested parties can reach out through their contact form on the website or email them directly to discuss potential partnerships and collaborative drug discovery projects.
Atomwise offers a range of solutions including virtual screening, lead optimization, and predictive modeling using advanced AI techniques. Their platform is designed to streamline the drug discovery process, making it more efficient and cost-effective.
To stay informed about Atomwise's latest news and developments, you can subscribe to their newsletter via the website. Additionally, following them on social media platforms like LinkedIn and Twitter will provide regular updates on their activities and innovations.
Atomwise Staff Directory
Search Atomwise Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
